3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2025

被引:2
作者
Amer Diabet Assoc Professional Practice Comm, Nuha A.
Elsayed, Nuha A.
McCoy, Rozalina G.
Aleppo, Grazia
Balapattabi, Kirthikaa
Beverly, Elizabeth A.
Early, Kathaleen Briggs
Bruemmer, Dennis
Ebekozien, Osagie
Echouffo-Tcheugui, Justin B.
Ekhlaspour, Laya
Gaglia, Jason L.
Garg, Rajesh
Khunti, Kamlesh
Lal, Rayhan
Lingvay, Ildiko
Matfin, Glenn
Pandya, Naushira
Pekas, Elizabeth J.
Pilla, Scott J.
Polsky, Sarit
Segal, Alissa R.
Seley, Jane Jeffrie
Stanton, Robert C.
Bannuru, Raveendhara R.
机构
关键词
LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; MEDICAL NUTRITION THERAPY; COST-EFFECTIVENESS; ISLET AUTOIMMUNITY; PHYSICAL-ACTIVITY; CONSENSUS REPORT; WEIGHT-LOSS; FOLLOW-UP; INSULIN-RESISTANCE;
D O I
10.2337/dc25-S003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
引用
收藏
页码:S50 / S58
页数:9
相关论文
共 121 条
  • [11] Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
    Bray, George A.
    Edelstein, Sharon L.
    Crandall, Jill P.
    Aroda, Vanita R.
    Franks, Paul W.
    Fujimoto, Wilfred
    Horton, Edward
    Jeffries, Susan
    Montez, Maria
    Mudaliar, Sunder
    Pi-Sunyer, F. Xavier
    White, Neil H.
    Knowler, William C.
    [J]. DIABETES CARE, 2012, 35 (04) : 731 - 737
  • [12] Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
    Cai, Ting
    Abel, Lucy
    Langford, Oliver
    Monaghan, Genevieve
    Aronson, Jeffrey K.
    Stevens, Richard J.
    Lay-Flurrie, Sarah
    Koshiaris, Constantinos
    McManus, Richard J.
    Hobbs, F. D. Richard
    Sheppard, James P.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [13] Retention Among Participants in the National Diabetes Prevention Program Lifestyle Change Program, 2012-2017
    Cannon, Michael J.
    Masalovich, Svetlana
    Ng, Boon Peng
    Soler, Robin E.
    Jabrah, Rajai
    Ely, Elizabeth K.
    Smith, Bryce D.
    [J]. DIABETES CARE, 2020, 43 (09) : 2042 - 2049
  • [14] Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease
    Chen, Fang
    Su, Wenqing
    Becker, Shawn H.
    Payne, Mike
    Sweet, Cynthia M. Castro
    Peters, Anne L.
    Dall, Timothy M.
    [J]. PLOS ONE, 2016, 11 (10):
  • [15] Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study
    Chen, Yanyan
    Zhang, Ping
    Wang, Jinping
    Gong, Qiuhong
    An, Yali
    Qian, Xin
    Zhang, Bo
    Li, Hui
    Gregg, Edward W.
    Bennett, Peter H.
    Li, Guangwei
    [J]. DIABETOLOGIA, 2021, 64 (06) : 1279 - 1287
  • [16] Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
    Chiasson, JL
    Josse, RG
    Gomis, R
    Hanefeld, M
    Karasik, A
    Laakso, M
    [J]. LANCET, 2002, 359 (9323) : 2072 - 2077
  • [17] Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
    Crandall, Jill P.
    Mather, Kieren
    Rajpathak, Swapnil N.
    Goldberg, Ronald B.
    Watson, Karol
    Foo, Sandra
    Ratner, Robert
    Barrett-Connor, Elizabeth
    Temprosa, Marinella
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [18] Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial
    Dai, Xia
    Zhai, Lu
    Chen, Qingyun
    Miller, Joshua D.
    Lu, Lirong
    Hsue, Cunyi
    Liu, Lin
    Yuan, Xiaodan
    Wei, Wei
    Ma, Xiaojun
    Fang, Zhaohui
    Zhao, Wenpiao
    Liu, Yuhua
    Huang, Feng
    Lou, Qingqing
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (05)
  • [19] Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
    Davies, Melanie J.
    Aroda, Vanita R.
    Collins, Billy S.
    Gabbay, Robert A.
    Green, Jennifer
    Maruthur, Nisa M.
    Rosas, Sylvia E.
    Del Prato, Stefano
    Mathieu, Chantal
    Mingrone, Geltrude
    Rossing, Peter
    Tankova, Tsvetalina
    Tsapas, Apostolos
    Buse, John B.
    [J]. DIABETES CARE, 2022, 45 (11) : 2753 - 2786
  • [20] Exercise Dose and Diabetes Risk in Overweight and Obese Children A Randomized Controlled Trial
    Davis, Catherine L.
    Pollock, Norman K.
    Waller, Jennifer L.
    Allison, Jerry D.
    Dennis, B. Adam
    Bassali, Reda
    Melendez, Agustin
    Boyle, Colleen A.
    Gower, Barbara A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (11): : 1103 - 1112